D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 94 Citations 33,595 645 World Ranking 6390 National Ranking 3487

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cardiology
  • Heart failure

Darrel P. Francis mainly focuses on Internal medicine, Cardiology, Heart failure, Heart disease and Surgery. His study ties his expertise on Endocrinology together with the subject of Internal medicine. His Cardiology research is multidisciplinary, incorporating perspectives in Predictive value of tests and Systole.

Darrel P. Francis has included themes like Physical therapy, Breathing, Baroreflex and Hazard ratio in his Heart failure study. His Heart disease research incorporates elements of Peripheral, Retrospective cohort study, Proportional hazards model, Physical exercise and Survival analysis. His Survival rate and Interventional cardiology study in the realm of Surgery connects with subjects such as General theory and Poor prognosis.

His most cited work include:

  • Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). (806 citations)
  • Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure (657 citations)
  • Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. (615 citations)

What are the main themes of his work throughout his whole career to date?

Darrel P. Francis mainly investigates Internal medicine, Cardiology, Heart failure, Hemodynamics and Surgery. His study in Blood pressure, Ejection fraction, Coronary artery disease, Fractional flow reserve and Heart disease is done as part of Internal medicine. His work on Cardiac resynchronization therapy, Stenosis and Percutaneous coronary intervention as part of general Cardiology research is frequently linked to In patient, thereby connecting diverse disciplines of science.

His work investigates the relationship between Percutaneous coronary intervention and topics such as Placebo that intersect with problems in Randomized controlled trial. Darrel P. Francis has researched Heart failure in several fields, including Anesthesia, Breathing, Physical therapy and Intensive care medicine. Many of his studies on Surgery involve topics that are commonly interrelated, such as Meta-analysis.

He most often published in these fields:

  • Internal medicine (73.29%)
  • Cardiology (66.61%)
  • Heart failure (30.59%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (73.29%)
  • Cardiology (66.61%)
  • Coronary artery disease (10.40%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Cardiology, Coronary artery disease, Percutaneous coronary intervention and Randomized controlled trial are his primary areas of study. He incorporates Internal medicine and In patient in his research. His Cardiology study integrates concerns from other disciplines, such as Lesion and Confidence interval.

His Percutaneous coronary intervention study also includes fields such as

  • Conventional PCI together with Angioplasty,
  • Placebo which intersects with area such as Stratified analysis. His Randomized controlled trial study combines topics in areas such as Clinical trial and Crossover study. Many of his studies on Heart failure apply to Blood pressure as well.

Between 2017 and 2021, his most popular works were:

  • Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. (419 citations)
  • Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. (419 citations)
  • Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis. (150 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cardiology
  • Heart failure

His primary scientific interests are in Internal medicine, Cardiology, Coronary artery disease, Randomized controlled trial and Percutaneous coronary intervention. His Internal medicine study frequently draws connections between related disciplines such as Placebo. His study in Cardiology focuses on Heart failure, Hemodynamics, Stenosis, Ablation and Atrial fibrillation.

The various areas that Darrel P. Francis examines in his Heart failure study include Bundle of His, Breathing and Respiration. His Randomized controlled trial research incorporates themes from Clinical trial and Surrogate endpoint. His work carried out in the field of Percutaneous coronary intervention brings together such families of science as Conventional PCI and Stress Echocardiography.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH).

MF Piepoli;CH Davos;DP Francis;AJ Coats.
BMJ (2004)

1334 Citations

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

Mathias Rauchhaus;Wolfram Doehner;Darrel P. Francis;Constantinos Davos.
Circulation (2000)

1040 Citations

Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations

Judith A. Finegold;Perviz Asaria;Darrel P. Francis.
International Journal of Cardiology (2013)

1021 Citations

Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging

Stefan D. Anker;Wolfram Doehner;Mathias Rauchhaus;Rakesh Sharma.
Circulation (2003)

875 Citations

Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.

Gerhard Paul Diller;Konstantinos Dimopoulos;Darlington Okonko;Wei Li.
Circulation (2005)

857 Citations

Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study.

Sayan Sen;Javier Escaned;Iqbal S. Malik;Ghada W. Mikhail.
Journal of the American College of Cardiology (2012)

819 Citations

Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

Rasha Al-Lamee;Rasha Al-Lamee;David Thompson;David Thompson;Hakim-Moulay Dehbi;Sayan Sen;Sayan Sen.
The Lancet (2018)

811 Citations

Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation.

Massimo F. Piepoli;Viviane Conraads;Ugo CorrÁ;Kenneth Dickstein;Kenneth Dickstein.
European Journal of Heart Failure (2011)

781 Citations

The annual global economic burden of heart failure

Christopher Cook;Graham Cole;Perviz Asaria;Richard Jabbour.
International Journal of Cardiology (2014)

773 Citations

Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2).

D.P. Francis;W. Shamim;L.Ceri Davies;M.F. Piepoli.
European Heart Journal (2000)

589 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Darrel P. Francis

Ross Arena

Ross Arena

University of Illinois at Chicago

Publications: 134

Michael A. Gatzoulis

Michael A. Gatzoulis

Imperial College London

Publications: 110

Marco Guazzi

Marco Guazzi

University of Milan

Publications: 106

Piotr Ponikowski

Piotr Ponikowski

Wrocław Medical University

Publications: 99

Massimo F. Piepoli

Massimo F. Piepoli

Sant'Anna School of Advanced Studies

Publications: 93

Andrew J.S. Coats

Andrew J.S. Coats

University of Warwick

Publications: 92

John G.F. Cleland

John G.F. Cleland

University of Glasgow

Publications: 90

Jonathan Myers

Jonathan Myers

VA Palo Alto Health Care System

Publications: 89

Alun D. Hughes

Alun D. Hughes

University College London

Publications: 74

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 66

Stephan von Haehling

Stephan von Haehling

University of Göttingen

Publications: 62

Jan J. Piek

Jan J. Piek

University of Amsterdam

Publications: 58

Colin Berry

Colin Berry

University of Glasgow

Publications: 57

Thomas F. Lüscher

Thomas F. Lüscher

University of Zurich

Publications: 55

Javier Escaned

Javier Escaned

Hospital Clínico San Carlos

Publications: 54

Patrick W. Serruys

Patrick W. Serruys

National University of Ireland, Galway

Publications: 53

Trending Scientists

Viorel Barbu

Viorel Barbu

Alexandru Ioan Cuza University

Marco Laumanns

Marco Laumanns

ZF Friedrichshafen (Germany)

Werner Wagner

Werner Wagner

Karlsruhe Institute of Technology

Dian-Qing Li

Dian-Qing Li

Wuhan University

Sanglu Lu

Sanglu Lu

Nanjing University

Raymond Pictet

Raymond Pictet

Université Paris Cité

Renate Kunert

Renate Kunert

University of Natural Resources and Life Sciences

Sam P. Brown

Sam P. Brown

Georgia Institute of Technology

Max Gassmann

Max Gassmann

University of Zurich

Jang Yang Chang

Jang Yang Chang

National Health Research Institutes

Bruce A. Buffett

Bruce A. Buffett

University of California, Berkeley

Högne Jungner

Högne Jungner

University of Helsinki

Romain Valabregue

Romain Valabregue

Sorbonne University

Timothy W. Jones

Timothy W. Jones

Tennessee Department of Health

Allan Kornberg

Allan Kornberg

Duke University

Kevin Schawinski

Kevin Schawinski

ETH Zurich

Something went wrong. Please try again later.